How do you help academic entrepreneurs get their ideas from the lab bench to the market?

MaRS Innovation (MI) is the official commercialization agent for 15 of Toronto's leading research institutions. Technologies disclosed to us span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies.

MI taps into $1 billion of annual research and development in Toronto’s largest research hub. Located within the MaRS Discovery District building, we are a separate, not-for-profit organization and have an independent mandate, board of directors and staff.

MaRS Innovation is supported by the Networks of Centres of Excellence (federal funding body), the Ontario Government and by our members as part of a collective strategy to close the nation’s productivity gap and improve Canada’s economic security. In 2008, the Networks of Centres of Excellence for Commercialization and Research (CECR) awarded us $14.95 million over five years; we extended this funding by another $14.95 million in 2013. Combined with support from our members, industry partners and other in-kind contributions, MaRS Innovation and its companies have secured approximately $75 million in our six years of operations.

Creating an organization like MaRS Innovation is completely unprecedented. It demonstrates the readiness of Toronto’s academic, health care and research communities to unleash the benefits of clustering. Their willingness to experiment enables MI to see technologies emerging across our portfolio, combining both like minds and research assets, as we build the strongest possible start-up companies and license opportunities. 

MaRS Innovation

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Selected as recipient of the Society for Neuro-Oncology and National Brain Tumor Foundation basic science award for PhD thesis work exploring the interaction between p14ARF tumor suppressor and Transcription Termination Factor-1 (TTF-1).

National Brain Tumor Foundation Basic Science Award (2003)

Canadian Cancer Society volunteer

Terry Fox Run volunteer

p14ARF interacts with DAXX: effects on HDM2 and p53

The cell cycle: accelerators, brakes and checkpoints

The INK4A/ARF locus: roled in cell cycle control and apoptosis and implications for glioma growth

Chapter on cell cycle pathway and corresponding potential therapeutic interventions for brain tumors.

"Regulation of the Cell Cycle and Interventional Developmental Therapeutics" in "Handbook of Brain Tumor Chemotherapy"

Discussion of gene therapy for brain tumors.

"Gene Therapy of Brain Tumors" in "Brain Tumors" (2nd edition)

Stacey obtained both her BSc, Honours (biology) and MSc (cancer genetics) from Queen’s University, and her PhD (molecular cancer biology) from the University of Toronto. After graduate studies, she worked as a scientific advisor in the Intellectual Property (IP) group of a leading Canadian law firm where she gained experience drafting and prosecuting patent applications, focusing on life sciences and biotechnology patent protection. Prior to joining MaRS Innovation in 2009, she worked as IP manager and strategist for a Montreal-based biotechnology startup and also as IP scout/advisor for a Toronto teaching hospital. 

Stacey's role at MaRS Innovation includes the development of IP strategy and commercialization plan for projects across a variety of sectors including therapeutics, biotechnology, imaging and healthcare IT. 



Intellectual Property Strategy

Access to Essential Medicines

Biotechnology Patent Protection

Early Stage Commercialization

English

"Intellectual property protection is a game small businesses can’t afford to lose"

Intellectual Property and Commercialization

Research Commercialization: Primer on Health Technology

Introduction to Intellectual Property and Commercialization

Intellectual Property: What is it and how can you use it to build a business?

Improving Access to Medicines with a Pharmaceutical Patent Pool: Legal/Business and Antitrust Considerations"

Director, Intellectual Property

MaRS Innovation backs big thinkers with bold ideas. We support translational research emerging from our 15 academic member institutions by helping to bring their ideas to market. 

Together, we're discovering new ways our partners can launch and grow Canadian companies while changing lives.

Visit us at: http://bit.ly/1w5KGmx

Select Inquiry Type